Medcell Pharma β Ondansetron Exporter Profile
Indian Pharmaceutical Exporter Β· #15 for Ondansetron Β· $1.3M export value Β· DGFT Verified
Medcell Pharma is the #15 Indian exporter of Ondansetron with $1.3M in export value and 32 verified shipments. Medcell Pharma holds a 1.1% market share in Ondansetron exports across 3 countries. The company exports 6 pharmaceutical products worth $7.5M across 4 therapeutic categories.
Medcell Pharma β Ondansetron Export Profile: Buyers & Destinations

Where Does Medcell Pharma Export Ondansetron?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TURKEY | $128.9K | 7 | 45.6% |
| IRAQ | $90.6K | 5 | 32.0% |
| AFGHANISTAN | $63.2K | 21 | 22.4% |
Medcell Pharma exports Ondansetron to 3 countries. The largest destination is TURKEY accounting for 45.6% of Medcell Pharma's Ondansetron shipments, followed by IRAQ (32.0%) and AFGHANISTAN (22.4%). These destinations reflect Medcell Pharma's established distribution network and regulatory approvals in key markets.